ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

UPCI wins NCI SPORE grant for head and neck cancer.

September 24, 2004

NCI, Private Groups, Promote Mammograms To Blacks, Hispanics

April 25, 1992

Senate Confirms Elias Zerhouni For NIH Director

May 3, 2002

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level

July 2, 1999

GAO Suggest NIG Stop Automatic Funding Of Non Competing Grants, Pay Higher Percent Of New Grants

August 13, 1976